Patent Assignment
Reel/Frame 046065/0549
Collateral Acceptance Agreement
Recorded: 2018-05-03
Pages: 13
Assignor
SOLACE PHARMACEUTICALS UK LTD.
Executed: 2010-08-10
Assignee
HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Property
(1)
Sepiapterin Reductase Inhibitors for the Treatment of Pain
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 3, 2018
From: BLAGG, JULIAN
To: SOLACE PHARMACEUTICALS UK LTD.
Reel/Frame 045706/0296 →
Assignment of Assignor's Interest
May 3, 2018
From: HERCULES TECHNOLOGY MANAGEMENT CO V, INC.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 045706/0797 →
Notice of Acceptance of Collateral in Partial Satisfaction of Obligations of Solace Pharmaceuticals, Inc.
May 3, 2018
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: HERCULES TECHNOLOGY MANAGEMENT CO V, INC.
Reel/Frame 046065/0567 →
Release by Secured Party
May 3, 2018
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: SOLACE PHARMACEUTICALS UK LTD.
Reel/Frame 046476/0470 →